Ciltacabtagene autoleucel, a B-cell maturation antigen-direc...

🤖 Plain-English Summary

This research explores Ciltacabtagene autoleucel, a B-cell maturation antigen-direc..., contributing new insights to the field of Medicine & Biology.

🔑 Key Findings

Research demonstrates significant advances in patient outcome data
Study provides new evidence regarding clinical efficacy results
Findings open new directions for biological mechanism insights

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📜 Copyright Notice: This page shows only metadata (title, authors, journal, date) and an original AI-generated summary. No abstract or full article text is copied. The original research is the intellectual property of its authors and publisher. ScienceTrace does not reproduce copyrighted content.

← More Medicine & Biology All Research Articles

📋 Article Details

Category	🧬 Medicine & Biology
Published	Jun 24, 2021
Journal	The Lancet
Authors	Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha
DOI	10.1016/s0140-6736(21)00933-8
Citations	1,653
Source	OpenAlex

🗂️ Research Categories

🤖 Artificial Intelligence 🧬 Medicine & Biology ⚛️ Physics & Space Science ⚙️ Engineering & Technology ∑ Mathematics

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

🤖 Plain-English Summary

🔑 Key Findings

💡 Why This Matters

📋 Article Details

🗂️ Research Categories

🔗 Related Resources

More 🧬 Medicine & Biology Research